Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

65.82 +0.89 (+1.38%)
Streaming Delayed Price Updated: 1:37 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Viking Thera

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
3 Biotech Stocks With Skyrocketing Potential: April 2024
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time. 
Via InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits. 
Via InvestorPlace
Topics Economy
Exposures Economy
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Good news could be just around the corner for two drugmakers not named Novo Nordisk. 
Via The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
These two pharma stocks have followed distinct paths of late. Which is the better investment? 
Via The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
This Vanguard growth fund is home to some of the world's most innovative companies. 
Via The Motley Fool
Looking At Viking Therapeutics's Recent Unusual Options Activity
Via Benzinga
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
These stocks to buy are set to surpass analyst expectations, with exciting product and service developments sparking unforeseen growth. 
Via InvestorPlace
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? 
Via InvestorPlace
Viking Therapeutics: Strong Results In Obesity
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100... 
Via Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
There's no guarantee these stocks will double by 2030, but their growth prospects look great. 
Via The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now. 
Via InvestorPlace
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
Is it Too Late to Buy Viking Therapeutics Stock?
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate. 
Via The Motley Fool
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
The drugmaker isn't losing momentum. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
Via Benzinga
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments. 
Via InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
These rising drugmakers have serious arguments in their favor. 
Via The Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate. 
Via The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
Shares of the clinical-stage biotech have skyrocketed on recent good news. 
Via The Motley Fool
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
These businesses should see good times ahead. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
Its long-term growth potential looks like it's improving, again. 
Via The Motley Fool
2 Potentially Explosive Stocks to Buy in April
These two healthcare stocks should have plenty of room to run. 
Via The Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
Viking shares have soared recently on optimism about its program. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
5 Healthcare Stocks to Buy for 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 
Via InvestorPlace
Tuesday Talk: April Is The Cruelest Month?
At least that is what the poet T.S. Eliot wrote in the opening line of his well-known poem, 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.